Sort by
Refine Your Search
-
) to understand and address the needs of cognitively diverse populations, ranging from individuals with cognitive deficits (due to disease, injury, or development) to neurotypical individuals across the lifespan
-
-world problems in the fields of Biology, Health, and Engineering. An effective research program will execute use-inspired discovery with an entrepreneurial mindset that develops science and solutions
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Zevra Therapeutics is offering a two-year Global Medical
-
disciplines to work on research projects on human-AI interaction. Increasing ability to generate human-AI interaction data needs to be matched with interdisciplinary perspectives to develop original
-
state and federal agencies. The appointment is for one year with the possibility of renewal based on performance. Key Responsibilities Lead research and development of a prototype community readiness
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Zevra Therapeutics is offering a two-year Global Medical
-
group aims to bring fundamental changes in the way the sensors and electronic devices are developed using materials designed for sustainability, and resource efficient printed electronics on flexible
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Eidos, a BridgeBio Pharma, Inc. Affiliate, is offering a two
-
with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering